EW:NYSE
Edwards Lifesciences Corp
86,60Â USD
arrow_downward
−1,68%(−1,48) 1 D
30. sep., 15:55:31 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for EW …
Ã…pne
87,16Â USD
Høy
87,49Â USD
Lav
85,72Â USD
Markedsverdi
49,92Â mrd.
Snittvolum
3,17Â mill.
Volum
2,83Â mill.
P/E-forhold
50,10
52 u høy
96,29Â USD
52Â u lav
72,30Â USD
EPS
1,73Â USD
Beta
0,85
Utestående aksjer
576,40Â mill.
Antall ansatte
16k
Ã…pne
87,16Â USD
Høy
87,49Â USD
Lav
85,72Â USD
Markedsverdi
49,92Â mrd.
Snittvolum
3,17Â mill.
Volum
2,83Â mill.
P/E-forhold
50,10
52 u høy
96,29Â USD
52Â u lav
72,30Â USD
EPS
1,73Â USD
Beta
0,85
Utestående aksjer
576,40Â mill.
Antall ansatte
16k
Profil
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Om Edwards Lifesciences Corp
Administrerende direktør-
Ansatte16k
Grunnlagt1958
HovedkontorIrvine, California, USA
Sektor-
Nettstededwards.com